Esonics Group is a professional company engaged in the research, development, and manufacturing of inhalation drug delivery devices and systems, with its headquarters located in Shanghai. The group′s product portfolio is comprehensive, covering pressured metered dose inhaler drug delivery devices and components, dry powder inhalation devices, soft mist inhalation devices, nebulizer drug delivery devices and nasal drug delivery devices, etc...The group is also conducting research and development in the forward-looking areas such as smart inhalation devices and other advanced drug delivery technologies, aiming to establish a full-category platform for oral and nasal inhalation drug delivery systems.
Esonics Group owns subsidiaries such as eSonics, PharmaCan, and InhalerTech, each responsible for different business segments. Among the individual divisions, PharmaCan is the global leader in the manufacturing of pMDI components e. g. Canisters, actuators and metering vavles, capable of designing, developing, and manufacturing a full range of pMDI canisters in various sizes, including aluminum plain cans, stainless steel cans, FEP coated cans, and anodized cans, which are compatible with various pMDI valves, actuators, and drug formulations.
Esonics Group has a strong R&D team and has obtained and applied for over 70 patents. With years of collaborative growth with customers in the pharmaceutical and medical device industries domestically and abroad, the group has accumulated a lot of technical expertise and practical experience. It continues to promote technological innovation and product development, striving to provide customers with safe, efficient, and convenient inhalation drug delivery system solutions.
Esonics Group has two production bases which located in Shanghai and Ningbo, focusing on establishing a strict quality management system and advanced production equipment to ensure product quality and stability.
Looking forward, eSonics Group will continue to uphold the corporate spirit of "Focus, Innovation, Excellence", continuously advancing in technological innovation and market expansion, provide customers with higher-quality inhalation drug delivery products and services, and aspires to become a global leading enterprise of the inhalation drug delivery.
View All